Esprinet had a tough first half of 2023 reporting year-on-year decreases across several business lines in its latest financial results. Sales from contracts with customers stood at €1.9bn in H1,...
To continue reading this article...
Join CRN
- Enjoy full access to channelweb.co.uk - the UK’s top news source for the IT channel
- Gain the latest insights through market analysis and interviews with channel leaders
- Stay on top of key trends with the Insider weekly newsletter curated by CRN’s editor
- Be the first to hear about our industry leading events and awards programmes
Already a CRN member?